Stability of TEM beta-lactamase mutants hydrolyzing third generation cephalosporins. 1995

X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
Centre d'Ingénierie des Protéines, Université de Liège, Sart-Tilman, Belgium.

The stability properties of six natural mutants of the TEM-1 beta-lactamase have been studied. The glutamate to lysine substitution at positions 104 and 240 stabilize the enzyme. Conversely, the G238S mutant's decreased stability might reflect an altered conformation of the active site and thus be related to the modified substrate profile. The relative stability of the R164S and R164H mutants is explained by the formation of a hydrogen bond between these residues and Asp-179 conferring a somewhat different structure to the omega loop and thus also explaining the extended substrate profile of these mutants. The loss of stability of the R164H mutant with increasing pH values can be explained by the titration of a hydrogen bond between the N delta of His-164 and the O delta of Asp-179. The properties of the G238S + E104K double mutant which is the most active against third-generation cephalosporins result from a balance of destabilizing and stabilizing substitutions, and their effects seem to be additive. The behavior of the R164S + E240K mutant might be explained on the basis of a similar compensation phenomenon.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011489 Protein Denaturation Disruption of the non-covalent bonds and/or disulfide bonds responsible for maintaining the three-dimensional shape and activity of the native protein. Denaturation, Protein,Denaturations, Protein,Protein Denaturations
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
December 1994, Journal of molecular biology,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
December 1985, European journal of clinical microbiology,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
January 1984, The Italian journal of biochemistry,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
December 1995, Protein engineering,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
January 1982, Chemotherapy,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
August 1989, The Journal of antimicrobial chemotherapy,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
July 1995, The Medical clinics of North America,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
December 1987, Indian pediatrics,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
January 1982, The Medical clinics of North America,
X Raquet, and M Vanhove, and J Lamotte-Brasseur, and S Goussard, and P Courvalin, and J M Frère
July 1985, Iowa medicine : journal of the Iowa Medical Society,
Copied contents to your clipboard!